Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-11 10:08 am Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | Avoro Capital Advisors LLC | 0 0% | -1,525,000 (Position Closed) | View |
2022-02-03 4:41 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | BlackRock Inc. BLK | 1,385,235 5.2% | -107,784 (-7.22%) | View |
2021-12-20 4:51 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | BIOTECHNOLOGY VALUE FUND L P | 1,647,400 5.9% | 1,647,400 (New Position) | View |
2021-12-20 4:33 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 2,000,000 7.2% | 2,000,000 (New Position) | View |
2021-02-16 4:39 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0% | -761,666 (Position Closed) | View |
2021-02-16 4:15 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | TANG CAPITAL PARTNERS LP | 200,000 1.2% | -1,100,000 (-84.62%) | View |
2021-02-16 4:10 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II L.P. | 668,440 4.1% | -214,374 (-24.28%) | View |
2021-02-12 09:38 am Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RTW INVESTMENTS LP | 1,512,673 9.31% | 256,816 (+20.45%) | View |
2021-02-12 08:05 am Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | Avoro Capital Advisors LLC | 1,525,000 9.4% | 1,525,000 (New Position) | View |
2021-02-02 3:13 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | BlackRock Inc. BLK | 1,493,019 9.2% | 1,493,019 (New Position) | View |
2020-06-11 08:54 am Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RTW INVESTMENTS LP | 1,255,857 8.26% | 1,255,857 (New Position) | View |
2020-02-14 4:34 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 761,666 5.4% | 761,666 (New Position) | View |
2020-02-14 4:00 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | TANG CAPITAL PARTNERS LP | 1,300,000 8.9% | 519,153 (+66.49%) | View |
2019-12-16 5:11 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II L.P. | 882,814 6.2% | 882,814 (New Position) | View |
2019-10-31 4:43 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | TANG CAPITAL PARTNERS LP | 780,847 7.8% | 780,847 (New Position) | View |